Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Long-Term Debt Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Long-Term Debt
CHf1.8m
CAGR 3-Years
-30%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Long-Term Debt
$416.3m
CAGR 3-Years
124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Long-Term Debt
CHf2.5m
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Long-Term Debt
CHf95.7m
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Long-Term Debt
CHf5m
CAGR 3-Years
33%
CAGR 5-Years
16%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Long-Term Debt?
Long-Term Debt
1.8m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Long-Term Debt amounts to 1.8m CHF.

What is Molecular Partners AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-1%

Over the last year, the Long-Term Debt growth was -40%. The average annual Long-Term Debt growth rates for Molecular Partners AG have been -30% over the past three years , -1% over the past five years .

Back to Top